Dr Timothy Spelman
Research Statistician
Department of Surgery
604 Scholarly works
8 Projects
HIGHLIGHTS
2026
Journal article
Corrigendum to “Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study” [Multiple Sclerosis and Related Disorders Vol 106; Feb 2026; Article Number 106885] (Multiple Sclerosis and Related Disorders (2026) 106, (S2211034825006236), (10.1016/j.msard.2025.106885))
DOI: 10.1016/j.msard.2026.1071312025
Research grants (ARC, NHMRC, MRFF)
Australian SPine Registry (ASPIRE) - Collecting, Analysing, Evaluating and Protecting Australians After Spine Surgery
2023
Research contracts (non-grants)
Effect of Subcutaneous Tirzepatide Once-Weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA): A Randomized, Double-Blind, Placebo-Controlled Trial
2021
Journal article
Associations of Disease-Modifying Therapies with COVID-19 Severity in Multiple Sclerosis
DOI: 10.1212/WNL.00000000000127532016
Research Grant
Centre for Research Excellence in Total Joint Replacement Optimising Outcomes, Equity, Cost Effectiveness and Patient Selection (Opus)
2015
Journal article
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
DOI: 10.1002/ana.243392013
Journal article
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
DOI: 10.1093/brain/awt281
RECENT SCHOLARLY WORKS
2026
Journal article
Ocrelizumab Discontinuation vs. Continuation After Safety Events: Comparative Insights from MSBase.
DOI: 10.2174/011570159X4489012512280533182026
Journal article
A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malaria
DOI: 10.1016/j.immuni.2026.02.0032026
Journal article
QuantiFERON-CMV Monitoring Post-Allogeneic Hematopoietic Stem Cell Transplantation Is Dynamic and Predictive of Immediate Cytomegalovirus Outcomes
DOI: 10.1111/tid.701522026
Journal article
Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial
DOI: 10.1093/cid/ciaf4092026
Journal article
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis: An MSBase registry sub-study
DOI: 10.1016/j.msard.2025.1068852026
Journal article
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry
DOI: 10.1007/s00415-026-13632-42026
Journal article
Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA)
DOI: 10.1016/j.jtocrr.2025.1009242026
Journal article
Perceived stress in mothers of children with and without islet and coeliac autoimmunity in the ENDIA study
DOI: 10.1007/s00125-025-06584-3